OliX Pharmaceuticals, Inc (KOSDAQ:226950)
South Korea · Delayed Price · Currency is KRW 135,300
+300 (0.22%)
Jul 7, 2026, 1:05 PM KST
OliX Pharmaceuticals Market Cap
OliX Pharmaceuticals has a market cap or net worth of 2.74 trillion as of July 6, 2026. Its market cap has increased by 195.18% in one year.
Market Cap
2.74T
Enterprise Value
2.66T
Revenue
17.26B
Ranking
n/a
PE Ratio
n/a
Stock Price
135,300.00
Market Cap Chart
Since July 18, 2018, OliX Pharmaceuticals's market cap has increased from 422.03B to 2.74T, an increase of 550.09%. That is a compound annual growth rate of 26.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 2.74T | -3.21% |
| Dec 30, 2025 | 2.83T | 697.30% |
| Dec 30, 2024 | 355.53B | 52.22% |
| Dec 28, 2023 | 233.57B | -16.24% |
| Dec 29, 2022 | 278.86B | -50.37% |
| Dec 30, 2021 | 561.83B | -17.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kolon TissueGene | 7.67T |
| SK Biopharmaceuticals | 6.75T |
| HLB Co., Ltd. | 6.43T |
| LigaChem Biosciences | 4.93T |
| Peptron | 4.21T |
| D&D Pharmatech | 3.63T |
| Voronoi | 3.22T |
| SK bioscience | 2.96T |